Aytu BioPharma to Report Fiscal 2026 Third Quarter Operational and Financial Results on May 13, 2026
DENVER, CO / ACCESS Newswire / May 6, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central ...
In the absence of regulations like those championed by the FTC, Consumer Reports and the State of Maryland, the public has to ...
Year in the First QuarterCompany Raises Full Year 2026 Revenue and Adjusted EBITDA ExpectationsSANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” ...
Where you live, your ethnicity and what you search can completely change the price you pay.
The Economic Hardship Reporting Project and Hammer and Hope report on Trump-era job cuts, highlighting Black women's ...
Eastport Critical Metals Corp. is pleased to provide an operational update covering the period from which the Company ...
Bet $5, get $150 in Bonus Bets If Your Bet Wins with our FanDuel sportsbook offer for new users.
Our guide to the best NBA betting sites & apps uses first person testing, analysis and expert breakdowns to offer a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results